Immunovia Publishes Interim Report for January-June 2023
/PRNewswire/ -- April-June 2023 Net sales amounted to kSEK 412 (103) divided by sales of tests kSEK 351 (45) and royalties kSEK 61 (58). Net earnings were MSEK...
Source: prnewswire.com
Page 5 - Jeff Borcherding News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jeff Borcherding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jeff Borcherding Today - Breaking & Trending Today
Invitation to Immunovia's Q2 presentation
/PRNewswire/ -- Immunovia will publish its second quarter 2023 results on August 30, 2023 at 8:30 am CET. Analysts, investors and media are invited to a...
Source: prnewswire.com
Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detect
LUND, Sweden, July 12, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company...
Source: europapress.es
Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection
/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced plans to...
Source: prnewswire.com
Chief Executive Officer, Jeff Borcherding, buys Immunovia shares
/PRNewswire/ -- Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has purchased 350 000 shares for approximately 670...
Source: prnewswire.com